BX - PTC cut to Neutral at Truist on financing and regulatory concerns
2023-10-06 10:52:41 ET
More on PTC Therapeutics
- PTC Therapeutics: Struggling Still But Potential Remains
- PTC Therapeutics, Inc. (PTCT) Q2 2023 Earnings Call Transcript
- PTC Technologies announces workforce reduction impacting 25% of the company
- Citi lowers PTC Therapeutics to neutral amid uncertainty for DMD drug
- Seeking Alpha’s Quant Rating on PTC Therapeutics
For further details see:
PTC cut to Neutral at Truist on financing and regulatory concerns